Pneumonia: all 2,072 studies
Page 12 of 21. Open to participants first (286), then studies with results posted, then the rest; newest registration first within each.
- Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 InfectionStatus unknownNCT04363814Phase 3
- Obstructive Sleep Apnea & Covid-19 OutcomesStatus unknownNCT04363333
- Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive UnitStatus unknownNCT04363060Phase 3
- Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 PneumoniaStatus unknownNCT04362345
- Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem CellsCompletedNCT04361942Phase 2
- Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical TrialWithdrawnNCT04360876Phase 2
- Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19CompletedNCT04359706
- Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With TocilizumabStatus unknownNCT04359667
- Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 PneumoniaCompletedNCT04358783Phase 2
- Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19No longer availableNCT04358588
- COVID-19 Mortality Prediction ModelCompletedNCT04358510
- Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath CondensateCompletedNCT04358419
- Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related PneumoniaCompletedNCT04357457Phase 3
- The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19CompletedNCT04357340Not applicable
- Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 InfectionTerminatedNCT04356443
- Inhaled Corticosteroid Treatment of COVID19 Patients With PneumoniaCompletedNCT04355637Phase 4
- SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19No longer availableNCT04355494
- Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID)Status unknownNCT04355429Phase 2
- Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 PneumoniaStatus unknownNCT04355026Phase 4
- International Lung UltraSound Analysis (ILUSA) StudyStatus unknownNCT04353141
- Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19Status unknownNCT04351152Phase 3
- Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 PneumoniaCompletedNCT04349618Not applicable
- Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 PneumoniaTerminatedNCT04348448
- Respiratory Infection in Older PatientsCompletedNCT04347395Not applicable
- Convalescent Antibodies Infusion in Critically Ill COVID 19 PatientsTerminatedNCT04346589Not applicable
- Efficacy of Early Administration of Tocilizumab in COVID-19 PatientsTerminatedNCT04346355Phase 2
- Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19Status unknownNCT04346147Phase 2
- Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial)TerminatedNCT04345861Phase 2/3
- Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 PneumoniaTerminatedNCT04345289Phase 3
- Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical TrialTerminatedNCT04344951Phase 2
- Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 PneumoniaStatus unknownNCT04344730Not applicable
- Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected PatientsStatus unknownNCT04344509
- Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)Status unknownNCT04344431Phase 2/3
- Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 InfectionTerminatedNCT04344288Phase 2
- Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19CompletedNCT04343729Phase 2
- Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare ProvidersStatus unknownNCT04341519
- Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 PneumoniaStatus unknownNCT04339660Phase 1/2
- Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation StudyStatus unknownNCT04338568Not applicable
- Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.Status unknownNCT04337840
- Checkpoint Blockade in COVID-19 PandemicTerminatedNCT04335305Phase 2
- Defibrotide in COVID-19 PneumoniaCompletedNCT04335201Phase 2
- Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 PneumoniaCompletedNCT04334850Not applicable
- Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related PneumoniaStatus unknownNCT04332913
- TOFAcitinib in SARS-CoV2 PneumoniaStatus unknownNCT04332042Phase 2
- Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 PneumoniaTerminatedNCT04331665Not applicable
- Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 PneumoniaCompletedNCT04329650Phase 2
- Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS)CompletedNCT04329507
- Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.CompletedNCT04328688
- Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare WorkersTerminatedNCT04328285Phase 3
- Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 PandemiaStatus unknownNCT04326725
- The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated PneumoniaCompletedNCT04325685Not applicable
- Prognostic Factors Keeping Track for COVID-19 PneumoniaCompletedNCT04324684
- Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane OxygenationCompletedNCT04324528Not applicable
- Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2CompletedNCT04323527Phase 2
- Use of Ascorbic Acid in Patients With COVID 19Status unknownNCT04323514Not applicable
- The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia.CompletedNCT04323150Not applicable
- Colchicine Counteracting Inflammation in COVID-19 PneumoniaCompletedNCT04322565Phase 2
- Simple, Safe, Same: Lung Ultrasound for COVID-19CompletedNCT04322487
- Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)CompletedNCT04321278Phase 3
- Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19)Status unknownNCT04320056Not applicable
- Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus PneumoniaStatus unknownNCT04319900Phase 2/3
- Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)Status unknownNCT04317092Phase 2
- NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 PneumoniaCompletedNCT04315987Phase 2
- Trial of Treatments for COVID-19 in Hospitalized AdultsCompletedNCT04315948Phase 3
- Tocilizumab for SARS-CoV2 (COVID-19) Severe PneumonitisStatus unknownNCT04315480Phase 2
- The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus PneumoniaStatus unknownNCT04314271
- Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-RaysStatus unknownNCT04313946
- Accurate Classification System for Patients With COVID-19 PneumonitisCompletedNCT04302688
- Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem CellsStatus unknownNCT04302519Early Phase 1
- Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 PneumoniaWithdrawnNCT04298814
- A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or RecurrenceCompletedNCT04298606Early Phase 1
- Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal PneumoniaStatus unknownNCT04296383Not applicable
- Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)Status unknownNCT04295551Not applicable
- Therapy for Pneumonia Patients iInfected by 2019 Novel CoronavirusWithdrawnNCT04293692Not applicable
- Clinical Progressive Characteristics and Treatment Effects of 2019-novel CoronavirusStatus unknownNCT04292327
- Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 InfectionWithdrawnNCT04290858Phase 2
- CT Scores Predict Mortality in 2019-nCoV PneumoniaCompletedNCT04284046
- Study for Novel Coronavirus Pneumonia (NCP)Status unknownNCT04283396
- Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral PneumonianStatus unknownNCT04282928Phase 1
- A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus InfectionStatus unknownNCT04282902Phase 3
- Molecular Biomarkers for SepsisTerminatedNCT04280354
- NK Cells Treatment for COVID-19CompletedNCT04280224Phase 1
- Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial PneumoniaCompletedNCT04279873
- A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus PneumoniaCompletedNCT04276987Phase 1
- Xiyanping Injection for the Treatment of New Coronavirus Infected PneumoniaStatus unknownNCT04275388
- Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV PneumoniaCompletedNCT04275245Phase 1/2
- Safety and Efficacy of the Tong-Fu-Xing-Shen Herbal Formula for Stroke-Associated PneumoniaStatus unknownNCT04275219Phase 4
- Assessing Health Related Quality of Life in Hypersensitivity PneumonitisCompletedNCT04273867
- Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)Status unknownNCT04273763Not applicable
- Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19Status unknownNCT04273646Not applicable
- The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) PneumoniaStatus unknownNCT04273529Phase 2
- Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) PneumoniaStatus unknownNCT04269525Phase 2
- Severe Pneumonia In Children (S-PIC) Study: A Comparative Effectiveness Study Of Children With Severe Pneumonia In AsiaCompletedNCT04265287
- Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured PatientsStatus unknownNCT04264858Not applicable
- Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected PneumoniaTerminatedNCT04264533Phase 2
- The Efficacy of Different Hormone Doses in 2019-nCoV Severe PneumoniaStatus unknownNCT04263402Phase 4
- Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19CompletedNCT04261517Phase 3
- The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected PneumoniaStatus unknownNCT04261426Phase 2/3
- Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel CoronavirusCompletedNCT04260594Phase 4
- A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus PneumoniaStatus unknownNCT04260308